Furthermore, omentin-1, an anti-inflammatory adipokine that inhibits TNF-induced vascular inflammation, exhibit low levels in patients with active CD and UC (82), emphasising the profound connection between IBD and adipose tissue
Nat Rev Endocrinol Nature Publishing Group
Rat studies examining transected tendons revealed that BPC-157 treatment restored biomechanical properties to near-normal levels
On average, clinical trials have found that patients on semaglutide (the active ingredient in Ozempic and Wegovy) may lose between 15% to 20% of their body weight within the first year of use
[12] The more severe form, called "colonic inertia", is the condition in which eating and prokinetics does not lead to increase in motor activity and HAPCs
What weight data do the studies on orforglipron show